Cargando…
The impact and cost-effectiveness of introducing the 10-valent pneumococcal conjugate vaccine into the paediatric immunisation programme in Iceland—A population-based time series analysis
INTRODUCTION: Streptococcus pneumoniae is a cause of infections that range in severity from acute otitis media (AOM) to pneumonia and invasive pneumococcal disease (IPD). The 10-valent pneumococcal conjugate vaccine (PHiD-CV10) was introduced into the Icelandic paediatric immunisation programme in 2...
Autores principales: | Eythorsson, Elias, Ásgeirsdóttir, Tinna L., Erlendsdóttir, Helga, Hrafnkelsson, Birgir, Kristinsson, Karl G., Haraldsson, Ásgeir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031404/ https://www.ncbi.nlm.nih.gov/pubmed/33831049 http://dx.doi.org/10.1371/journal.pone.0249497 |
Ejemplares similares
-
Impact of the 10-valent pneumococcal conjugate vaccine on antimicrobial prescriptions in young children: a whole population study
por: Eythorsson, Elias, et al.
Publicado: (2018) -
The Effect of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine on H. influenzae in Healthy Carriers and Middle Ear Infections in Iceland
por: Sveinsdóttir, Hildigunnur, et al.
Publicado: (2019) -
Increase in tympanostomy tube placements despite pneumococcal vaccination, a population‐based study
por: Eythorsson, Elias, et al.
Publicado: (2019) -
Vaccination of Icelandic Children with the 10-Valent Pneumococcal Vaccine Leads to a Significant Herd Effect among Adults in Iceland
por: Quirk, Sigríður J., et al.
Publicado: (2019) -
Reduction of antimicrobial resistant pneumococci seven years after introduction of pneumococcal vaccine in Iceland
por: Hjálmarsdóttir, Martha Á., et al.
Publicado: (2020)